P-Alaxin
A Dihydroartemisinin-Piperaquine brand by Greenlife Pharmaceutical — tablet, made in India.
NAFDAC registration
Our July 2026 copy of the NAFDAC Greenbook lists P-Alaxin (Dihydroartemisinin 40 mg & Piperaquine 320 mg) Tablets — registration number 04-9495 — with status Active.
P-Alaxin at a glance
- Generic name
- Dihydroartemisinin-Piperaquine
- Manufacturer
- Greenlife Pharmaceutical
- Form
- Tablet
- Composition
- Dihydroartemisinin 40 mg; Piperaquine Phosphate 320 mg
- Made in
- India
- NAFDAC reg. no.
- 04-9495
P-Alaxin price in Nigeria
Online pharmacy listings for Dihydroartemisinin-Piperaquine products ranged from ₦2,090 to ₦2,800 (median ₦2,350) as of July 2026.
For tablet/capsule products specifically, listings ranged ₦2,090–₦2,090 (median ₦2,090).
Figures cover Dihydroartemisinin-Piperaquine products across brands and pack sizes, sampled from licensed Nigerian online pharmacies — indicative only. Track month-by-month movement on the Medicine Price Index.
About Dihydroartemisinin-Piperaquine
Dihydroartemisinin-Piperaquine (commonly known by the popular brand name P-Alaxin or Duo-Cotexcin) is an Artemisinin-based Combination Therapy (ACT) used for treating uncomplicated malaria. It has become one of the most popular antimalarial drugs in Nigeria, largely because of its convenient once-daily dosing. While the more established ACT, Artemether-Lumefantrine (Coartem/Lonart), requires doses to be taken twice a day for three days, Dihydroartemisinin-Piperaquine only needs to be taken once a day for three days, making it easier for patients to complete the full course. This better adherence means a higher chance of completely clearing the malaria parasite from the body.
Read the full Dihydroartemisinin-Piperaquine guide — dosage, side effects, warnings, and all registered brands.
Frequently asked questions
Registration details are shown exactly as recorded in the NAFDAC Greenbook (our copy: July 2026). Listings can lag renewals — always confirm current status on the official Greenbook before acting on it. Content updated July 2026.